These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35221261)

  • 1. Pregnancy in Alpha 1 Antitrypsin (AAT) Deficiency and the role of intravenous AAT therapy.
    Guarnieri G; Achille A; Lococo S; Vianello A
    Pulmonology; 2022; 28(4):317-319. PubMed ID: 35221261
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy in patients with Alpha 1 Antitrypsin (AAT) deficiency and the role of intravenous AAT therapy. Authors' reply.
    Guarnieri G; Achille A; Lococo S; Vianello A
    Pulmonology; 2022; 28(5):411-412. PubMed ID: 35501281
    [No Abstract]   [Full Text] [Related]  

  • 3. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM; Louie SG
    Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
    Blanco I; Canto H; de Serres FJ; Fernandez-Bustillo E; Rodríguez MC
    J Rheumatol; 2004 Oct; 31(10):2082-5. PubMed ID: 15468381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha-1 antitrypsin in human health and disease.
    de Serres F; Blanco I
    J Intern Med; 2014 Oct; 276(4):311-35. PubMed ID: 24661570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT; Ford GT; Chapman KR;
    Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation therapy for alpha(1)-antitrypsin deficiency.
    Juvelekian GS; Stoller JK
    Drugs; 2004; 64(16):1743-56. PubMed ID: 15301559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Sandhaus RA
    COPD; 2009 Jun; 6(3):147-8. PubMed ID: 19811367
    [No Abstract]   [Full Text] [Related]  

  • 18. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy.
    Gross B; Grebe M; Wencker M; Stoller JK; Bjursten LM; Janciauskiene S
    Dermatology; 2009; 218(4):370-5. PubMed ID: 19218787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe postoperative wound healing disturbance in a patient with alpha-1-antitrypsin deficiency: the impact of augmentation therapy.
    Cathomas M; Schüller A; Candinas D; Inglin R
    Int Wound J; 2015 Oct; 12(5):601-4. PubMed ID: 25818083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.
    Sandhaus RA; Turino G; Stocks J; Strange C; Trapnell BC; Silverman EK; Everett SE; Stoller JK;
    Chest; 2008 Oct; 134(4):831-834. PubMed ID: 18842915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.